Validation of a Novel Fluorescent Lateral Flow Assay for Rapid Qualitative and Quantitative Assessment of Total Anti-SARS-CoV-2 S-RBD Binding Antibody Units (BAU) from Plasma or Fingerstick Whole-Blood of COVID-19 Vaccinees

Background: Limited commercial LFA assays are available to provide a reliable quantitative measurement of the total binding antibody units (BAU/mL) against the receptor-binding domain of the SARS-CoV-2 spike protein (S-RBD). Aim: This study aimed to evaluate the performance of the fluorescence LFA F...

Descripción completa

Detalles Bibliográficos
Autores principales: Younes, Nadin, Al-Sadeq, Duaa W., Shurrab, Farah M., Zedan, Hadeel T., Abou-Saleh, Haissam, Abo-Halawa, Bushra Y., AlHamaydeh, Fatima M., Elsharafi, Amira E., Daas, Hanin I., Thomas, Swapna, Aboalmaaly, Sahar, Al Farsi, Afra, Al-Buainain, Reeham, Ataelmannan, Samar, Paul, Jiji, Al Saadi, Amana Salih, Yassine, Hadi M., Majdalawieh, Amin F., Ismail, Ahmed, Abu-Raddad, Laith J., Nasrallah, Gheyath K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415525/
https://www.ncbi.nlm.nih.gov/pubmed/36016206
http://dx.doi.org/10.3390/vaccines10081318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415525/
https://www.ncbi.nlm.nih.gov/pubmed/36016206
http://dx.doi.org/10.3390/vaccines10081318

Ejemplares similares